Delivery Order SPE2DB22D2211-SPE2DB26FRGVX
- Not listed
- The Defense Logistics Agency awarded a $1,454.25 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction typical of the Defense Logistics Agency's Medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,031.24 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. This non-competitive delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025, and carries firm fixed pricing. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary distribution center for federal...
- The Defense Logistics Agency awarded a $1,637.16 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed-price, non-set-aside contract with a completion date of August 26, 2025, and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the agency. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award is...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.60 to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Proctofoam-HC 1%-1% foam in 10-gram units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by July 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,048.10 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% foam in a 10-gram unit. This award, issued on August 20, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 21, 2025, and was competitively awarded without a set-aside designation. The product will be delivered to the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $1,643.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Proctofoam-HC 1%-1% foam in 10-gram units. The order, which is not set-aside, is scheduled for completion by September 26, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's existing prime indefinite delivery contract with DLA Troop...
- The Defense Logistics Agency awarded a $2,863.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. Awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, this non-set-aside contract represents a small-value medical supply procurement. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Proctofoam-HC 1%-1% foam in a 10-gram unit, with a ceiling value of $1,048.10. This competitively awarded contract uses firm fixed pricing and is classified as a non-set-aside procurement. The delivery order is expected to be completed by August 18, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,724.56 on September 3, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 4, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,276.46 to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam in 10-gram units. This non-set-aside, competitively awarded contract operates under a firm fixed price structure with a completion date of July 25, 2025. The delivery order was issued on July 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical supply...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB26FRGVXDelivery Order
The Defense Logistics Agency awarded a $1,335.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit. The award was issued on October 17, 2025, with an ultimate completion date of October 20, 2025. This delivery order represents a non-set-aside, competitively awarded transaction and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a broad portfolio of medications and medical products to support military and veteran healthcare systems. The company's contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill diverse pharmaceutical procurement requirements, ranging from specialty medications and generic drugs to medical devices and supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 10/17/25 |